Dynamic 99mTc-Tetrofosmin CZT-SPECT Myocardial Perfusion Imaging in Comparison With Fractional Flow Reserve in Patients After ST-elevation Myocardial Infarction
Condition: Myocardial Infarction Intervention: Diagnostic Test: Dynamic 99mTc-Tetrofosmin CZT-SPECT Sponsor: Nantes University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2023 Category: Research Source Type: clinical trials
Sponsor-Initiated OCS Liver Perfusion (OLP-II) Registry
Condition: Liver Transplant Intervention: Device: OCS Liver Sponsor: TransMedics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2023 Category: Research Source Type: clinical trials
Dynamic 99mTc-Tetrofosmin CZT-SPECT Myocardial Perfusion Imaging in Comparison With Fractional Flow Reserve in Patients After ST-elevation Myocardial Infarction
Condition: Myocardial Infarction Intervention: Diagnostic Test: Dynamic 99mTc-Tetrofosmin CZT-SPECT Sponsor: Nantes University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2023 Category: Research Source Type: clinical trials
CMR in T2DM: The NSR Cohort
Conditions: Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Cardiovascular Magnetic Resonance Imaging; Coronary Microvascular Dysfunction; Myocardium; Fibrosis Intervention: Diagnostic Test: All subjects will undergo cardiac magnetic resonance imaging with gadolinium contrast and with adenosine myocardial perfusion Sponsors: Slagelse Hospital; Herlev Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
Sponsor-Initiated OCS Heart Perfusion Registry
Condition: Heart Transplant Intervention: Device: OCS Heart Sponsor: TransMedics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
CMR in T2DM: The NSR Cohort
Conditions: Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Cardiovascular Magnetic Resonance Imaging; Coronary Microvascular Dysfunction; Myocardium; Fibrosis Intervention: Diagnostic Test: All subjects will undergo cardiac magnetic resonance imaging with gadolinium contrast and with adenosine myocardial perfusion Sponsors: Slagelse Hospital; Herlev Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
Sponsor-Initiated OCS Heart Perfusion Registry
Condition: Heart Transplant Intervention: Device: OCS Heart Sponsor: TransMedics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
CMR in T2DM: The NSR Cohort
Conditions: Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Cardiovascular Magnetic Resonance Imaging; Coronary Microvascular Dysfunction; Myocardium; Fibrosis Intervention: Diagnostic Test: All subjects will undergo cardiac magnetic resonance imaging with gadolinium contrast and with adenosine myocardial perfusion Sponsors: Slagelse Hospital; Herlev Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
Sponsor-Initiated OCS Heart Perfusion Registry
Condition: Heart Transplant Intervention: Device: OCS Heart Sponsor: TransMedics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
CMR in T2DM: The NSR Cohort
Conditions: Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Cardiovascular Magnetic Resonance Imaging; Coronary Microvascular Dysfunction; Myocardium; Fibrosis Intervention: Diagnostic Test: All subjects will undergo cardiac magnetic resonance imaging with gadolinium contrast and with adenosine myocardial perfusion Sponsors: Slagelse Hospital; Herlev Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
Sponsor-Initiated OCS Heart Perfusion Registry
Condition: Heart Transplant Intervention: Device: OCS Heart Sponsor: TransMedics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
CMR in T2DM: The NSR Cohort
Conditions: Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Cardiovascular Magnetic Resonance Imaging; Coronary Microvascular Dysfunction; Myocardium; Fibrosis Intervention: Diagnostic Test: All subjects will undergo cardiac magnetic resonance imaging with gadolinium contrast and with adenosine myocardial perfusion Sponsors: Slagelse Hospital; Herlev Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
Sponsor-Initiated OCS Heart Perfusion Registry
Condition: Heart Transplant Intervention: Device: OCS Heart Sponsor: TransMedics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
CMR in T2DM: The NSR Cohort
Conditions: Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Cardiovascular Magnetic Resonance Imaging; Coronary Microvascular Dysfunction; Myocardium; Fibrosis Intervention: Diagnostic Test: All subjects will undergo cardiac magnetic resonance imaging with gadolinium contrast and with adenosine myocardial perfusion Sponsors: Slagelse Hospital; Herlev Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
Sponsor-Initiated OCS Heart Perfusion Registry
Condition: Heart Transplant Intervention: Device: OCS Heart Sponsor: TransMedics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
